Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Entero Therapeutics Inc
ENTO
Healthcare
Biotechnology
Entero Therapeutics, Inc., formerly First Wave BioPharma, Inc., is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. Its programs address unmet needs in GI health and include latiglutenase, a Phase III-ready, oral biotherapeutic designed to aid gluten digestion and potentially reduce symptoms of...
celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for multiple GI conditions, including gastroparesis, and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency. The Company also intends to develop Niclosamide, an oral small molecule anti-inflammatory inhibitor therapy for the treatment of ulcerative proctitis and ulcerative proctosigmoiditis, and immune checkpoint inhibitor-associated colitis and diarrhea in metastatic cancer patients.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:ENTO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Next
(68)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Sep 23, 2021 11:00am
RE:FWBI ...... I will start a small position .....
LMFAO....That was fast ....now in the red......going to pick my spot now Cheers !
(68)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Sep 23, 2021 10:56am
FWBI ...... I will start a small position .....
if this goes green to red today Currently green.... up 2 cents trading at ~ $3.54 Cheers !
BioVaxys' DPX Exhibits Superior Immune System Activation Compared to Aqueous and Emulsion-Based Antigen Delivery Systems
posted Oct 31, 2024 9:00am by
BioVaxys Technology Corp.
-
|
"BioVaxys is at the forefront of a significant shift in the drug delivery landscape," James Passin, CEO of BioVaxys, stated, "These groundbreaking study results validate our strategic position in an important segment of the multi-billion drug delivery market. DPX not only outperforms current antigen delivery solutions but also demonstrate ...read more
(68)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Sep 23, 2021 10:21am
FWBI ....... It's a done deal......
AZRX is now FWBI On watch and will be a shareholder before you can say $FiveForty.... Cheers !
(68)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Sep 21, 2021 1:03pm
AZRX ...... RS Merger & NC.....
The full 9 yards..... On watch AzurRx BioPharma to Change Corporate Name to First Wave BioPharma Today 2021-09-21 09:48 PT - News Release BOCA RATON, Fla., Sept. 21
...more
(217)
•••
askretka
X
View Profile
View Bullboard History
Post by
askretka
on Mar 25, 2021 8:32pm
Up 9.76% today
Better than most. Always nice to see buying of a stock you own on a down day.
(217)
•••
askretka
X
View Profile
View Bullboard History
Post by
askretka
on Mar 23, 2021 2:48pm
Welcome mevani
$3.50 target reiterated today. By analyst. Glad I'm not just here talking to myself anymore. Let's make some more money! Cheers!
(2)
•••
mevani
X
View Profile
View Bullboard History
Comment by
mevani
on Mar 18, 2021 1:12am
RE:Moving again up nice todat
News any day now. I am loaded and locked. Good luck to you.
(217)
•••
askretka
X
View Profile
View Bullboard History
Post by
askretka
on Mar 15, 2021 10:16am
Moving again up nice todat
low target on this is 3$ US I'm back in 2nd time around with free shares. Cheers!
(217)
•••
askretka
X
View Profile
View Bullboard History
Post by
askretka
on Feb 16, 2021 1:05pm
Bought back in today new Target $3.50
Analyst raises target from 2$ to $3.50 Bought back in with smaller position for longer term.
(217)
•••
askretka
X
View Profile
View Bullboard History
Post by
askretka
on Jan 25, 2021 7:22pm
SOLD TODAY 150% profit in a few days
Long term I think it has lots of potential but over 150% profit since the 13 January too hard to resist. Cheers!
(217)
•••
askretka
X
View Profile
View Bullboard History
Post by
askretka
on Jan 22, 2021 9:34pm
Up 48% today. Up 35.5% Yesterday
Not sure what tomorrow will bring But looks like this stock is in play.
(217)
•••
askretka
X
View Profile
View Bullboard History
Post by
askretka
on Jan 22, 2021 12:53pm
Up 69% on the day at the moment
Bought in a 0.86 recently. Hope a couple other people got on board.
(217)
•••
askretka
X
View Profile
View Bullboard History
Post by
askretka
on Jan 22, 2021 9:09am
2$ Buy target maintained today
By HC Wainwright analyst Yi Chen ---- That's the low 1yr target on this stock AVERAGE 4$ HIGH $7 CHEERS!
(217)
•••
askretka
X
View Profile
View Bullboard History
Post by
askretka
on Jan 21, 2021 8:21pm
UP 34.5 % today
Long term Biotech play. Current New average Analyst Target 4.00 3 products now scheduled for trials. 3 shots on goal for 2021. Billion dollar markets.
(217)
•••
askretka
X
View Profile
View Bullboard History
Post by
askretka
on Jan 21, 2021 3:20pm
Up 45% at.moment
Wonder where we will endvthe day?
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Be a Part of a Gold Company Before it Catches the Attention of the Market’s Major Players
Canadian Miner Launches Private Placement for Ambitious Alaskan Gold Project
A Swedish Solution to Break European Dependency on China for Critical Raw Materials
Prospera Energy corporate update: 3 years of strategic restructuring, recovery and future growth
Tribe Property Technologies Provides Update on Tribe Home, Demonstrating Increased Efficiencies with Property Management Platform
Breakthrough in Cancer Vaccine Tech: New Platform Outshines Traditional Methods in Immune Activation
Learn how to Trade on the U.S. Election and other Economic and Environmental Events
Major Copper-Gold Discovery Revealed! High-Grade Rock Samples Signal Untapped Potential
Discover Options Trading Strategies to Minimize your Tax Burden